This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08194/identifier/chemspider/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08194/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08194/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB08194/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08194/identifier/drugbank/

Statements

Subject Item
n2:DB08194
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB08194 n11:DB08194
dcterms:title
4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
adms:identifier
n4:99444665 n7:MO8 n10:2726820 n13:2008878 n14:DB08194
n5:IUPAC-Name
n6:271B4068-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B406E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B406D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B406A-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B406B-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B406C-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4066-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4064-363D-11E5-9242-09173F13E4C5 n6:271B4067-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4065-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4074-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4075-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B406F-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4070-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4072-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4071-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4073-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B407A-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B407C-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B407D-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4079-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4078-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B407B-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4069-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4076-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4077-363D-11E5-9242-09173F13E4C5